Evaluation of the pharmaceutical quality of docetaxel injection using new stability indicating chromatographic methods for assay and impurities

Scientia Pharmaceutica

Volumn 78, Issue 2, 2010, Pages 215-231

  Malleswara Reddy, Annarapu ^a   Banda, Nagaraju ^a   Govind Dagdu, Shinde ^a   Rao, Dama Venugopala ^a   Kocherlakota, Chandra Sekhar ^a   Krishnamurthy, Vyas ^a  

^a DR REDDY'S LABORATORIES LTD   (India)

Author keywords

Docetere; Excipients; HPLC; Impurities; Quality; Stability indicating

Indexed keywords

DOCETAXEL; PACLITAXEL; POLYSORBATE 80;

ARTICLE; CHROMATOGRAPHY; DRUG FORMULATION; DRUG STABILITY; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 77954644210     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.0912-14     Document Type: Article

References (13)

1. Taxotere Summary of product Characteristics: http://www.emea.europa.eu/humandocs/PDFs/EPAR/taxotere/H-073-PI-en.pdf
2. Taxotere Label information http://www.fda.gov/cder/foi/label/2007/020449s045lbl.pdf
3. Vasu DR, Moses Babu J, Vyas K, Sai RP, Ramachandra P,Sekhar NM, Reddy DNM, Srinivasa NR Isolation and characterization of impurities in docetaxel. J Pharm Biomed Anal. 2006; 40: 614-622. doi:10.1016/j.jpba.2005.10.037
4. Kumar D, Tomar RS, Deolia SK, Mitra M, Mukherjee R, Burman AC. Isolation and characterization of degradation impurities in docetaxel drug substance and its formulation. J Pharm Biomed Anal. 2007; 43: 1228-1235. doi:10.1016/j.jpba.2006.10.015
5. Rao BM, Chakraborty A, Srinivasu MK, Lalitha Devi M, Kumar PR, Chandrasekhar KB, Srinivasan AK, Prasad AS, Ramanatham J. A stability-indicating HPLC assay method for docetaxel. J Pharm Biomed Anal. 2006; 41: 676-681. doi:10.1016/j.jpba.2006.01.011
6. Pharmeuropa. Monograph: Docetaxel trihydrate, Vol.20, No.2 April 2008.
7. Ciccolini J, Catalin J, Blachon MF, Durand A. Rapid high-performance liquid chromatographic determination of docetaxel (Taxotere) in plasma using liquid-liquid extraction. J Chromatogr B Biomed Sci Appl. 2001; 759: 299-306. doi:10.1016/S0378-4347(01)00238-9
8. Loos WJ, Verweij J, Nooter K, Stoter G, Sparreboom A. Sensitive determination of docetaxel in human plasma by liquid-liquid extraction and reversed-phase high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 1997; 693: 437-441. doi:10.1016/S0378-4347(97)00089-3
9. Rouini MR, Lotfolahi A, Stewart DJ, Molepo JM, Shirazi FH, Vergniol JC, Tomiak E, Delorme F, Vernillet L, Giguere M, Goel R. A rapid reversed phase high performance liquid chromatographic method for the determination of docetaxel (Taxotere®) in human plasma using a column switching technique. J Pharm Biomed Anal. 1998; 17: 1243-1247. doi:10.1016/S0731-7085(97)00233-1
10. Long Yu J, Li Yan Q, Yi J. HPLC for determination of docetaxel by injection: Zhongguo Yiyao Gongye Zazhi. 2006; 37: 708-709.
11. Yang B, Lu-Xia Zheng, Geng-li Duan, Zhi-Zhong Chen. Determination of docetaxel and its related substances in injections by HPLC. J Fudan University (Medical Edition). 2006; 33: 701-703.
12. Vial J, Cohen M, Sassiat P, Thiébaut D. Pharmaceutical quality of docetaxel generics versus originator drug product: a comparative analysis: Curr Med Res Opin. 2008; 24: 2019-2033. doi:10.1185/03007990802207874
13. Stability Testing of New Drug Substances and Products (Q1AR2), ICH Harmonised: Tripartite Guideline.